富科伊丹的系统性特征:新药学干预措施的有趣特征
Seungjin Jeong1,2, Seokmin Lee1,2, Geumbin Lee1
1Department of Food Science Nutrition, Pukyong National University, Busan 48513, Republic of Korea.
International journal of molecular sciences
|November 9, 2024
概括
来自棕藻的富科丹表现出多样化的生物活动. 它的作用不仅取决于硫酸盐含量,还取决于结构,分子量和单糖组成,影响治疗潜力.
科学领域:
- 海洋生物技术 海洋生物技术
- 碳水化合物化学 碳水化合物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 富科伊丹是一种来自棕藻的硫化多糖,被认为具有各种生物活动.
- 从历史上看,硫酸盐含量被认为是富可伊丹生物活性的主要驱动因素.
- 最近的进展表明,多糖体结构,单体组成和分子量也显著影响生物效应.
研究的目的:
- 综合回顾富可伊丹的结构特征,包括单糖化合物组成,硫化程度,分子量分布和甘油酸链接.
- 为了将这些多样化的结构特征与富科伊丹的不同生物活动联系起来.
- 讨论福科伊丹对未来应用和治疗用途的影响.
主要方法:
- 对分析富可伊丹结构和生物活动的研究进行文献综述.
- 综合了关于单糖组成,硫化模式,分子量和结合类型的数据.
- 结构参数与报告的生物效应之间的相关性分析.
主要成果:
- 富科伊丹在不同来源和提取方法中表现出显著的结构异质性.
- 生物活动是通过硫酸盐含量,特定单糖形状,分子量和糖键连接的组合来调节的.
- 这些结构元素的变化导致广泛的观察到的生物活性.
结论:
- 富科伊丹的生物效应是复杂和多因素的,不仅仅是硫酸盐含量.
- 了解复杂的结构-活动关系对于优化福柯丹的治疗应用至关重要.
- 对富科伊丹多样化的结构属性的进一步研究将释放其在医学和生物技术中的全部潜力.
相关概念视频
01:29Drugs for Treatment of Ulcerative Colitis in IBD
120
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
120
01:27Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
01:26Targets for Drug Action: Overview
6.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.0K
01:15Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
114
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
114
01:21Drug Distribution: Tissue Binding
2.6K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.6K